Using multi-criteria decision analysis to appraise orphan drugs: a systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using multi-criteria decision analysis to appraise orphan drugs: a systematic review

Published:2017-12-20 Issue:2 Volume:18 Page:135-146
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Friedmann Carlotta¹,Levy Pierre²,Hensel Paul¹,Hiligsmann Mickaël¹^ORCID

Affiliation:

1. Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands

2. Université Paris-Dauphine, Laboratoire d’Économie et de Gestion des Organisations de Santé (LEDa-LEGOS), Paris, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1414603

Reference56 articles.

1. EUROPEAN DRUG REIMBURSEMENT SYSTEMS' LEGITIMACY: FIVE-COUNTRY COMPARISON AND POLICY TOOL

2. SIMILARITIES AND DIFFERENCES BETWEEN FIVE EUROPEAN DRUG REIMBURSEMENT SYSTEMS

3. Framework for describing and classifying decision-making systems using technology assessment to determine the reimbursement of health technologies (fourth hurdle systems)

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Issues, Challenges and Opportunities for Economic Evaluations of Orphan Drugs in Rare Diseases: An Umbrella Review;PharmacoEconomics;2024-04-14

2. Current scenario and challenges of clinical pharmacists to implement pharmaceutical care in DRG/DIP payment hospitals in China: a qualitative interview study;Frontiers in Public Health;2024-02-20

3. Developing a Framework of Cost Elements of Socioeconomic Burden of Rare Disease: A Scoping Review;PharmacoEconomics;2023-04-07

4. A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain;Global & Regional Health Technology Assessment;2022-01-25

5. Methods and criteria for the assessment of orphan drugs: a scoping review;International Journal of Technology Assessment in Health Care;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3